Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
320
Trial Sponsor
Clinical Trial Start Date
July 2, 2018
0Primary Completion Date
September 3, 2018
0Study Completion Date
October 26, 2018
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Prevention0
Intervention Type
Drug0
Intervention Name
Bupivacaine liposome injectable suspension0
Bupivacaine HCl without epinephrine via continuous infusion0
Interventional Trial Phase
Phase 40
Official Name
A Randomized, Phase 4 Study of the Efficacy, Safety, and Pharmacokinetics of Bupivacaine Administered as Liposomal Bupivacaine or Continuous Infusion Via Elastomeric Pump Following Unilateral Open Inguinal Herniorrhaphy0
Last Updated
September 26, 2019
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
None (Open Label)0
Study summary
This is a phase 4, randomized, open-label study of the efficacy, safety, and pharmacokinetics of bupivacaine administered as liposomal bupivacaine or continuous infusion via elastomeric pump following unilateral open inguinal herniorrhaphy.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
